Seven TFs (FOXA1, FOXA2, RARG, STAT4, MEF2C, SOX18, and GXS2) have been identified to be likely to affect the metabolism, development, differentiation and proliferation of liver cancer in previous studies. This evidence concerns the gene RARG and liver cancer.